Literature DB >> 34127026

Anti-Xa activity and hemorrhagic event: isn't it time to consider time ?

Sébastien Redant1,2, Xavier Beretta-Piccoli3, Patrick M Honore4, David De Bels4, Dominique Biarent3.   

Abstract

Entities:  

Year:  2021        PMID： 34127026     DOI： 10.1186/s13054-021-03612-7

Source DB:  PubMed          Journal:  Crit Care        ISSN： 1364-8535            Impact factor:   9.097


× No keyword cloud information.
  4 in total

1.  Anticoagulation Management and Antithrombin Supplementation Practice during Veno-venous Extracorporeal Membrane Oxygenation: A Worldwide Survey.

Authors:  Alessandro Protti; Giacomo E Iapichino; Matteo Di Nardo; Mauro Panigada; Luciano Gattinoni
Journal:  Anesthesiology       Date:  2020-03       Impact factor: 7.892

2.  Prediction of massive blood transfusion in cardiac surgery.

Authors:  Keyvan Karkouti; Rachel O'Farrell; Terrence M Yau; W Scott Beattie
Journal:  Can J Anaesth       Date:  2006-08       Impact factor: 5.063

3.  Evaluation of Anti-Xa and Activated Partial Thromboplastin Time Monitoring of Heparin in Adult Patients Receiving Extracorporeal Membrane Oxygenation Support.

Authors:  Serena Arnouk; Diana Altshuler; Tyler C Lewis; Cristian Merchan; Deane E Smith; Bridget Toy; Bishoy Zakhary; John Papadopoulos
Journal:  ASAIO J       Date:  2020-03       Impact factor: 2.872

4.  Anti-Xa activity and hemorrhagic events under extracorporeal membrane oxygenation (ECMO): a multicenter cohort study.

Authors:  Richard Descamps; Mouhamed D Moussa; Emmanuel Besnier; Marc-Olivier Fischer; Sébastien Preau; Fabienne Tamion; Cédric Daubin; Nicolas Cousin; André Vincentelli; Julien Goutay; Damien Du Cheyron
Journal:  Crit Care       Date:  2021-04-02       Impact factor: 9.097
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.